Article
Cell-free synthesis of anticoagulant heparan sulfate reveals a limiting converting activity that modifies an excess precursor pool.
The Journal of biological chemistry - 25 Oct 1996
Shworak N W, Fritze L M, Liu J, Butler L D, Rosenberg R D
Abstract excerpt
LTA cells synthesize a minor population of heparan sulfate proteoglycans (HSPGact) bearing anticoagulant heparan sulfate (HSact) with a specific monosaccharide sequence that accelerates the action of antithrombin (AT). LTA cells also synthesize a major population of heparan sulfate proteoglycans endowed with nonanticoagulant heparan sulfate (HSinact) lacking the AT-binding site. To investigate the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
